ALEXA EL KADI: Open Payments
NPI 1417542036 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 14 payments from 8 companies in 2025. Trend: 2023 $320 · 2024 $391 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $115 |
| COLOPLAST CORP | 2 | $35 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| UROGEN PHARMA, INC. | 1 | $17 |
Products named: GEMTESA, Luja Coude, PYLARIFY, PURIFIED CORTROPHIN GEL, Venxxiva, VOYXACT, ADSTILADRIN.
Industry payments across VA — which companies pay providers there.
